-
GBT Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Global Blood Therapeutics (GBT)
Company Profile
Quarter (USD) | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 263.58 mm | 263.58 mm | 263.58 mm | 263.58 mm | 263.58 mm | 263.58 mm |
Cash burn (monthly) | 43.56 mm | 13.18 mm | 27.43 mm | 26.15 mm | 14.77 mm | 20.78 mm |
Cash used (since last report) | 1.40 bn | 422.74 mm | 879.88 mm | 838.90 mm | 473.83 mm | 666.76 mm |
Cash remaining | -1.13 bn | -159.15 mm | -616.29 mm | -575.32 mm | -210.24 mm | -403.17 mm |
Runway (months of cash) | -26.0 | -12.1 | -22.5 | -22.0 | -14.2 | -19.4 |
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|